1-6 of 6
James S. Duncan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment

Lynn Jeanette Savic, Isabel Theresa Schobert, Dana Peters, John J. Walsh, Fabian Max Laage-Gaupp, Charlie Alexander Hamm, Nina Tritz, Luzie A. Doemel, MingDe Lin, Albert Sinusas, Todd Schlachter, James S. Duncan, Fahmeed Hyder, Daniel Coman, Julius Chapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (2): 428–438.
https://doi.org/10.1158/1078-0432.CCR-19-1702
Published: 15 January 2020
View article titled, Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment
Open the PDF for Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment in another window
Journal Articles

Abstract NTOC-087: DYNAMIC REPROGRAMMING OF THE KINOME OVERCOMES BET PROTEIN INHIBITION IN OVARIAN CANCER

Alison M. Kurimchak, Claude Shelton, Kelly E. Duncan, Katherine J. Johnson, Jennifer Brown, Shane O'Brien, Rashid Gabbasov, Lauren S. Fink, Yuesheng Li, Nicole Lounsbury, Magid Abou-Gharbia, Wayne E. Childers, Denise C. Connolly, Jonathan Chernoff, Jeffrey R. Peterson, James S. Duncan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11_Supplement): NTOC-087.
https://doi.org/10.1158/1557-3265.OVCASYMP16-NTOC-087
Published: 31 May 2017
View article titled, Abstract NTOC-087: DYNAMIC REPROGRAMMING OF THE KINOME OVERCOMES BET PROTEIN INHIBITION IN OVARIAN CANCER
Journal Articles

A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer

Anna V. Gaponova, Anna S. Nikonova, Alexander Y. Deneka, Meghan C. Kopp, Alexander E. Kudinov, Natalia Skobeleva, Vladimir Khazak, Luisa S. Ogawa, Kathy Q. Cai, Kelly E. Duncan, James S. Duncan, Brian L. Egleston, David A. Proia, Yanis Boumber, Erica A. Golemis
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (20): 5120–5129.
https://doi.org/10.1158/1078-0432.CCR-15-3068
Published: 13 October 2016
View article titled, A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
Open the PDF for A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B37: Monitoring kinome response to EGFR inhibition in triple negative breast cancer

Martin C. Whittle, James S. Duncan, Lee M. Graves, Gary L. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): B37.
https://doi.org/10.1158/1078-0432.MECHRES-B37
Published: 04 March 2013
View article titled, Abstract B37: Monitoring kinome response to EGFR inhibition in triple negative breast cancer
Open the PDF for Abstract B37: Monitoring kinome response to EGFR inhibition in triple negative breast cancer in another window
Journal Articles

Abstract B23: Reprogramming of the cancer kinome in response to targeted kinase inhibition

James S. Duncan, Marty W. Whittle, Lee M. Graves, Gary L. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): B23.
https://doi.org/10.1158/1078-0432.MECHRES-B23
Published: 04 March 2013
View article titled, Abstract B23: Reprogramming of the cancer kinome in response to targeted kinase inhibition
Open the PDF for Abstract B23: Reprogramming of the cancer kinome in response to targeted kinase inhibition in another window
Journal Articles

Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

Patrick J. Roberts, Jerry E. Usary, David B. Darr, Patrick M. Dillon, Adam D. Pfefferle, Martin C. Whittle, James S. Duncan, Soren M. Johnson, Austin J. Combest, Jian Jin, William C. Zamboni, Gary L. Johnson, Charles M. Perou, Norman E. Sharpless
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5290–5303.
https://doi.org/10.1158/1078-0432.CCR-12-0563
Published: 30 September 2012
View article titled, Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
Open the PDF for Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models in another window
Includes: Supplementary data